Dow to Cease Production and Marketing of Hydroxyalkyl Acrylates

The Dow Chemical Company announced its intent to stop producing and marketing hydroxyalkyl acrylates (HAA) by the end of 2007.

The HAA product line includes hydroxyethyl acrylate (HEA) and hydroxypropyl acrylate (HPA). These products are sold largely to major coatings formulators for use in automotive topcoat applications.

“Dow’s competitiveness in the HAA market has deteriorated significantly as a result of high raw material costs, industry overcapacity and declining demand with a shift to low acid HAA products,” explained Chris Kok, global HAA product manager. “Moreover, after carefully reviewing our options, we believe that we can generate more value by directing our resources and capital towards other promising growth initiatives that better fit with Dow’s emphasis on more innovative products and market-facing businesses. Our priority now is to ensure a seamless transition for our loyal customers and take whatever reasonable steps we can to minimize disruption for them.”

Dow will work closely with customers to manage last-time orders, which must be in by December 12, 2007, with delivery no later than November 12, 2008.

This decision has no impact on Dow’s standing as a leading acrylic acid and acrylic ester producer. Dow manages those products independently from the HAA line.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.